NCT05052853View on ClinicalTrials.gov

Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prodromal Schizophrenia
Interventions
DRUG

NMDAE

Use of an NMDA enhancer for the treatment of prodromal schizophrenia .

DRUG

Placebo Cap

Use of placebo as a comparator

Trial Locations (1)

Unknown

RECRUITING

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER